Inhaled CRISPR Treatment Targets Influenza and SARS-CoV-2 Infections
Inhaled CRISPR Treatment Targets Influenza and SARS-CoV-2 Infections March 5, 2021 If you think breathing in gene editing enzymes to treat infectious diseases, such as the flu or COVID-19, is a technology that is far-fetched or a long way off, think again. A team of investigators from the Georgia Institute of Technology and Emory University has developed a CRISPR-based treatment to stop the replication of both the flu virus and the virus that causes COVID-19 in mice. Moreover, the new treatment is delivered to the lungs via a nebulizer, which could make it simple for patients to administer th...
Source: genengnews.com